Cargando…
Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a progressive and devastating disease for which there is an escalating body of genetic and related pathophysiological information on disease pathobiology. Nevertheless, the success to date in identifying susceptibility genes, genetic variants and epigenetic p...
Autores principales: | Egom, Emmanuel Eroume-A, Moyou-Somo, Roger, Essame Oyono, Jean Louis, Kamgang, Rene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958998/ https://www.ncbi.nlm.nih.gov/pubmed/33732008 http://dx.doi.org/10.2147/TACG.S260755 |
Ejemplares similares
-
Pregnancy and breastfeeding during COVID-19
pandemic
por: Egom, Emmanuel Eroume-A, et al.
Publicado: (2020) -
Role of natriuretic peptide receptor C signalling in obesity-induced
heart failure with preserved ejection fraction with pulmonary
hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020) -
COVID-19 and myocarditis: a review of literature
por: Ali, Mohammed, et al.
Publicado: (2022) -
Pulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling?
por: Egom, Emmanuel Eroume-A
Publicado: (2019) -
Antioxidant potential of the methanol–methylene chloride extract of Terminalia glaucescens leaves on mice liver in streptozotocin-induced stress
por: Njomen, Guy Bertrand Sabas Nya, et al.
Publicado: (2008)